FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and is intended for relief of symptoms, prevention and/or treatment of cancer. Performed is introducion to subject, patient or person subjected to risk of cancer, one or several phosphate derivatives of one or more hydroxychromans, selected from group, which consists of 7:8-dimethyl-6-hydroxychromans, 8-methyl-6-hydroxychromans and their mixtures, together with one or more anticancer agents.
EFFECT: inventions make it possible due to application of effective quantity of composition of one or more hydrochromans with one or more anticancer agents and their combination to stimulate apoptosis of cancer cells, contributing to relief of symptoms, prevention and/or treatment of cancer.
24 cl, 4 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
| TRANSPORTING FILLER, WHICH CONTAINS ONE OR MORE DI- AND/OR MONO-(ELECTRONIC TRANSMITTING AGENT) PHOSPHATE DERIVATIVES OR THEIR COMPOUNDS | 2006 |
|
RU2434643C2 |
| CARRIER VEHICLE FOR ENTERAL APPLICATION | 2005 |
|
RU2377019C2 |
| ALKALOID FORMULATIONS | 2005 |
|
RU2477136C2 |
| LIPOSOME DELIVERY OF COMPOSITIONS BASED ON VITAMIN E | 2002 |
|
RU2328273C2 |
| CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
| SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2001 |
|
RU2264217C2 |
| COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER | 2016 |
|
RU2786570C2 |
| COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT | 2016 |
|
RU2752506C2 |
| SYNERGISTIC COMPOSITIONS AND METHODS | 2012 |
|
RU2657594C2 |
